Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib plus cytarabine versus imatinib alone in first chronic phase chronic myeloid leukemia
ISRCTN51564734Phase 3Completed
- Sponsor
- HOVON
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of imatinib and cytarabine in chronic myelogenous leukemia (CML), sponsored by HOVON. Started May 2006; status: completed.
02
Drugs
imatinibcytarabine
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on ISRCTN51564734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51564734.